Home » Healthcare » Pharmaceuticals » China Gastrointestinal Products Market

China Gastrointestinal Products Market By Devices (Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, Stenting Devices); By Indications (Gastrointestinal Cancers, Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, Inflammatory Bowel Disease, Other Diseases); By End-User (Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, Other End Users) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
China Gastrointestinal Products Market Size 2023	USD 1,679.04 million
China Gastrointestinal Products Market, CAGR	8.06%
China Gastrointestinal Products Market Size 2032	USD 3,375.67 million

Market Overview

The China Gastrointestinal Products Market is projected to grow from USD 1,679.04 million in 2023 to USD 3,375.67 million by 2032, with a compound annual growth rate (CAGR) of 8.06%.

The China gastrointestinal products market is driven by the increasing prevalence of digestive disorders, such as irritable bowel syndrome and gastroesophageal reflux disease (GERD), fueled by changing diets, stress, and sedentary lifestyles. Additionally, the growing aging population and rising awareness about digestive health are contributing to market expansion. Technological advancements in drug formulations and the availability of over-the-counter (OTC) products are further enhancing market growth. The trend toward personalized medicine, where treatments are tailored to individual patient needs, is gaining momentum, offering new opportunities for pharmaceutical companies. Moreover, the shift toward preventive healthcare and the demand for natural and organic products are influencing consumer choices. These factors are expected to support the growth of the gastrointestinal products market in China, with increasing investment in research and development further driving innovation and enhancing the therapeutic options available.

The geographical distribution of the China gastrointestinal products market is influenced by the country’s diverse healthcare infrastructure and regional demand for digestive health solutions. Key regions like Beijing, Shanghai, and Guangzhou are major hubs for the market, driven by advanced healthcare systems and a growing awareness of gastrointestinal disorders. The presence of leading healthcare institutions and a high concentration of consumers with access to premium medical treatments further support the market’s growth in these cities. Key players in the China gastrointestinal products market include global leaders like Boston Scientific Corporation, Olympus Corporation, Medtronic, and Stryker, as well as local companies such as Zhejiang Tiansong Medical Instrument Co. and PENTAX Medical. These companies are pivotal in driving innovation, offering a wide range of products for diagnosis and treatment, including endoscopy devices, biopsy tools, and stenting systems, to address the rising incidence of gastrointestinal diseases across the region.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The China gastrointestinal products market was valued at USD 1,679.04 million in 2023 and is expected to reach USD 3,375.67 million by 2032, growing at a CAGR of 8.06%.
Increasing prevalence of gastrointestinal disorders, such as GERD, IBS, and IBD, is a major driver of market growth.
The demand for over-the-counter (OTC) products and natural remedies is rising as consumers become more health-conscious.
Technological advancements in diagnostic tools, including endoscopy and biopsy devices, are transforming the market.
Competitive players like Boston Scientific, Olympus, and Medtronic are focusing on innovation to maintain market leadership.
Market restraints include high costs of advanced devices and complex regulatory processes that delay product launches.
Key regions driving market growth include Beijing, Shanghai, and Guangzhou, with increasing healthcare investments and consumer demand for gastrointestinal treatments.

Market Drivers

Advancements in Pharmaceutical Solutions

Technological innovations and advancements in pharmaceutical formulations are playing a vital role in driving the gastrointestinal products market in China. New drug delivery systems, more effective medications, and non-invasive treatments are improving patient outcomes and creating new market opportunities. For instance, recent advancements in biologic therapies and personalized medicine have significantly improved the treatment of chronic gastrointestinal diseases, as highlighted in a review by the Journal of Clinical Medicine. The development of biologics and personalized medicine, which tailors treatments based on genetic profiles, is enhancing the effectiveness of gastrointestinal therapies, leading to increased patient adoption and demand for advanced products.

Growing Awareness and Preventive Healthcare

The increasing awareness of digestive health and the shift toward preventive healthcare are significant drivers for the market. As the public becomes more conscious of the importance of gut health, demand for gastrointestinal products that support digestive wellness, including probiotics, dietary supplements, and natural remedies, is on the rise. For instance, the Healthy China 2030 initiative emphasizes the importance of preventive healthcare and has led to increased public awareness about digestive health. Additionally, the growing focus on early detection and management of GI conditions is motivating consumers to seek products that help manage symptoms and prevent future complications. This trend is encouraging greater investment in the gastrointestinal products market, resulting in a wider range of therapeutic options.

Increasing Prevalence of Digestive Disorders

The rising incidence of gastrointestinal (GI) disorders, such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and inflammatory bowel diseases (IBD), is a key driver for the China gastrointestinal products market. Changing dietary patterns, increased consumption of processed foods, and sedentary lifestyles are contributing factors to this surge. As more individuals seek relief from digestive ailments, the demand for both prescription and over-the-counter gastrointestinal products has significantly increased, prompting a boost in the market.

Aging Population

China’s aging population is another critical factor fueling the growth of the gastrointestinal products market. As people age, the frequency of digestive disorders tends to rise, creating a higher demand for GI treatments. Older adults are more likely to experience conditions like constipation, acid reflux, and gastric ulcers, which further intensifies the need for effective gastrointestinal solutions. Healthcare providers are focusing on age-specific treatments, which are contributing to the market’s expansion.

Market Trends

Shift Toward Over-the-Counter (OTC) Products

A notable trend in the China gastrointestinal products market is the increasing demand for over-the-counter (OTC) medications. Consumers are becoming more proactive about managing their digestive health, seeking convenient, easily accessible solutions. With the rise of self-diagnosis and health awareness, OTC products such as antacids, laxatives, and probiotics are gaining popularity. This trend is driven by a growing preference for non-prescription remedies, as individuals look for quick relief from common digestive issues without the need for doctor visits.

Growing Popularity of Natural and Organic Products

Consumers in China are increasingly leaning toward natural and organic gastrointestinal products. This trend is a response to the rising awareness about the potential side effects of synthetic drugs and a preference for products derived from natural ingredients. Probiotics, herbal supplements, and plant-based medications are in high demand as people seek alternatives that are perceived to be gentler on the digestive system. For instance, a report by the State Administration for Market Regulation noted that sales of organic products in China reached $14.2 billion in 2021, reflecting a significant increase in consumer demand for natural and organic options. This shift toward natural solutions is reshaping the product offerings of pharmaceutical companies, with many now investing in developing and marketing organic and plant-based gastrointestinal treatments.

Technological Innovations in Gastrointestinal Treatments

Advancements in technology are transforming the landscape of gastrointestinal treatments in China. The market is witnessing the introduction of innovative drug delivery systems, such as sustained-release formulations and targeted therapies, which enhance the effectiveness and convenience of treatment. Additionally, the rise of digital health tools, including mobile apps for tracking digestive health and telemedicine consultations, is revolutionizing patient care. These technological developments are not only improving treatment options but also creating new opportunities for companies to engage with consumers and offer tailored solutions for digestive health.

Personalized Medicine and Tailored Treatments

Personalized medicine is emerging as a key trend in the gastrointestinal products market in China. As more is understood about genetic factors that influence digestive health, treatments are becoming increasingly tailored to individual needs. This trend is being supported by advances in genomics and diagnostics, enabling healthcare providers to offer more precise therapies for conditions like IBS and IBD. With personalized treatments showing better efficacy and fewer side effects, this trend is expected to play a significant role in the future growth of the gastrointestinal products market in China.

Market Challenges Analysis

Regulatory and Approval Challenges

One of the primary challenges facing the China gastrointestinal products market is navigating the complex regulatory environment. The approval process for new gastrointestinal medications and treatments can be lengthy and costly, particularly for foreign companies attempting to enter the market. Stringent regulations and varying requirements for clinical trials, product testing, and safety standards can delay the introduction of innovative products. For instance, the National Medical Products Administration (NMPA) in China requires comprehensive clinical trials and detailed safety evaluations for new drug approvals, which can extend the approval timeline significantly. These regulatory hurdles may discourage some companies from launching new solutions or expanding their portfolios in China, which can limit market competition and slow down product availability for consumers.

Rising Competition and Price Sensitivity

The increasing competition within the gastrointestinal products market in China presents another challenge. As more companies enter the market, both local and international, price sensitivity among consumers has become a significant issue. Consumers are increasingly looking for affordable alternatives, especially for common gastrointestinal conditions like acid reflux and constipation. This price-consciousness puts pressure on manufacturers to maintain competitive pricing while still ensuring product quality and safety. Additionally, the influx of generic products, which often offer lower prices than branded medications, intensifies the competitive landscape, making it more difficult for companies to differentiate their products and capture market share.

Market Opportunities

The China gastrointestinal products market presents significant opportunities driven by the country’s growing healthcare needs and changing consumer preferences. With the rising incidence of digestive disorders such as irritable bowel syndrome, gastroesophageal reflux disease, and inflammatory bowel diseases, there is an increasing demand for both prescription and over-the-counter gastrointestinal solutions. The aging population, which tends to experience a higher incidence of gastrointestinal issues, also offers a substantial market opportunity for age-specific treatments and therapeutic interventions. Companies can capitalize on this trend by developing targeted products that address the specific needs of elderly patients, such as those with chronic constipation or acid reflux. Moreover, the growing focus on preventive healthcare and digestive wellness opens opportunities for products like probiotics, dietary supplements, and natural remedies, catering to consumers who prioritize maintaining gut health.

Another key opportunity lies in technological advancements and the rise of personalized medicine. Innovations in drug delivery systems, such as sustained-release formulations and biologics, offer the potential to enhance treatment effectiveness and patient compliance. Additionally, the integration of digital health tools, including mobile apps for monitoring digestive health, presents a unique opportunity to engage consumers and provide tailored solutions. Personalized treatments, based on genetic profiles and diagnostic data, are gaining traction in the Chinese market, offering more efficient and effective therapies for gastrointestinal conditions. By embracing these advancements, companies can differentiate themselves in the competitive landscape and meet the evolving demands of the Chinese consumer, ultimately driving growth in the gastrointestinal products sector.

Market Segmentation Analysis:

By Devices:

The China gastrointestinal products market can be segmented by devices, including endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices. Endoscopy devices hold a significant share of the market due to their widespread use in diagnosing and monitoring various gastrointestinal conditions, including cancers and inflammatory bowel disease (IBD). Ablation devices, used to treat gastrointestinal cancers, are also experiencing growth, driven by advancements in minimally invasive procedures. Motility testing devices are gaining traction due to the increasing prevalence of conditions like irritable bowel syndrome (IBS), as they help in assessing gut function. Biopsy and stenting devices are essential for diagnosing and managing gastrointestinal cancers and other disorders, contributing to market expansion. As the healthcare system in China continues to evolve, demand for these devices is expected to rise, creating opportunities for innovation and improved diagnostic and treatment capabilities.

By Indications:

In terms of indications, the gastrointestinal products market in China is driven by diseases such as gastrointestinal cancers, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other gastrointestinal disorders. Gastrointestinal cancers are a major contributor to market growth, with increasing incidence rates and growing awareness of early detection and treatment options. GERD and IBS are also significant indications, with rising stress levels and unhealthy eating habits leading to an increase in these conditions. IBD, which includes Crohn’s disease and ulcerative colitis, is another growing segment due to its chronic nature and the need for long-term treatment options. As the prevalence of these conditions rises, demand for innovative treatments and diagnostic tools tailored to each indication is expected to drive growth in the gastrointestinal products market in China.

Segments:

Based on Devices:

Endoscopy Devices
Ablation Devices
Motility Testing Devices
Biopsy Devices
Stenting Devices

Based on Indications:

Gastrointestinal Cancers
Gastroesophageal Reflux Disease
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Other Diseases

Based on End-User:

Hospitals
Ambulatory Surgical Centers & Independent Surgical Centers
Clinics
Other End Users

Based on the Geography:

Beijing
Shanghai
Guangzhou

Regional Analysis

Beijing

Beijing, as the political and economic center, holds a notable share of the gastrointestinal products market, accounting for around 20% of the total market. The city’s advanced healthcare infrastructure, high disposable income, and increasing demand for specialized treatments drive the market’s growth. The presence of top-tier hospitals and medical research centers also supports the development and distribution of cutting-edge gastrointestinal products, making Beijing a critical hub for the industry.

Shanghai

Shanghai, another major player in China’s gastrointestinal products market, holds a market share of approximately 18%. As a global financial center, Shanghai benefits from a large and diverse population with growing healthcare awareness. The city’s well-established healthcare system, coupled with a strong presence of multinational pharmaceutical companies, contributes to the increased availability of advanced gastrointestinal treatments. Additionally, Shanghai’s strategic location as a trade and logistics hub facilitates the distribution of gastrointestinal products across the region, further enhancing its market presence.

Guangzhou

Guangzhou, a rapidly growing metropolitan area in southern China, is another key region driving the gastrointestinal products market, with a market share of about 15%. Guangzhou’s healthcare sector has seen significant improvements, fueled by increased government investments and the expansion of healthcare facilities. The region’s proximity to Hong Kong also facilitates the import of international gastrointestinal products, enhancing the variety of treatment options available to consumers. Moreover, the rising incidence of gastrointestinal diseases in Guangzhou, coupled with the increasing awareness of digestive health, supports the growing demand for both prescription and over-the-counter gastrointestinal products.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Boston Scientific Corporation
Olympus Corporation
PENTAX Medical
Zhejiang Tiansong Medical Instrument Co
Medtronic
Stryker
Smith & Nephew
Karl Storz
Hoya
Company 10
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The China gastrointestinal products market is highly competitive, with key players focusing on innovation, strategic partnerships, and regional expansion to maintain market leadership. Leading companies like Boston Scientific Corporation, Olympus Corporation, PENTAX Medical, Zhejiang Tiansong Medical Instrument Co., Medtronic, Stryker, Smith & Nephew, Karl Storz, Hoya, and others are constantly advancing their product offerings to cater to the rising demand for gastrointestinal diagnostics and treatments. These companies provide a wide range of devices such as endoscopy instruments, biopsy tools, stenting devices, and motility testing solutions, targeting the growing prevalence of gastrointestinal diseases. For instance, advancements in endoscopic technologies have significantly improved diagnostic accuracy and patient comfort. To stay ahead in this competitive landscape, many players are investing heavily in R&D to enhance the precision and effectiveness of their products. Additionally, companies are expanding their presence in China’s key metropolitan areas like Beijing, Shanghai, and Guangzhou, where the demand for advanced healthcare solutions is rapidly increasing. Strategic collaborations, mergers, and acquisitions are also common among these companies to strengthen their market positions and diversify product portfolios. Despite the high level of competition, the continuous development of innovative technologies and a focus on patient-centric solutions are expected to drive the future growth of the gastrointestinal products market in China.

Recent Developments

In April 2023, Boston Scientific announced the launch of the EXALT Model B Single-use Bronchoscope, which expands its single-use endoscopy portfolio. This device is designed for diagnostic and therapeutic bronchoscopy procedures and offers high-resolution imaging and precise control.
In March 2023, Polifarma Spa expanded its gastrointestinal portfolio through a long-term distribution agreement with Devintec Pharma Sagl, a Lugano-based company known for pioneering substance-based medical devices and the Gelsectan brand.
In April 2023, Italian pharmaceutical innovator Azienda Farmaceutica Italiana partnered with TannerLAC, Inc. to distribute Hepilor, a medical device designed to protect the digestive system mucosa, throughout Latin America.
In May 2022, Dr. Reddy’s Laboratories Ltd. announced a partnership with South Korea’s HK inno.N Corporation to supply and commercialize HK inno.N’s patented novel molecule, Tegoprazan, for treating gastrointestinal diseases in India and six key emerging markets.
In March 2022, AbbVie Inc. received U.S. FDA approval for its novel drug, RINVOQ (upadacitinib), for the treatment of moderately to severely active ulcerative colitis.

Market Concentration & Characteristics

The China gastrointestinal products market is moderately concentrated, with a few dominant global players alongside emerging local companies that are progressively gaining market share. Large multinational corporations like Boston Scientific, Olympus, and Medtronic hold significant market influence, thanks to their extensive product portfolios, established brand recognition, and advanced technological capabilities. These companies lead the market with a wide range of products, including endoscopy devices, biopsy tools, and stenting systems, which cater to the rising demand for gastrointestinal diagnostics and treatments. At the same time, local players such as Zhejiang Tiansong Medical Instrument Co. and PENTAX Medical are becoming increasingly competitive by offering cost-effective alternatives and focusing on meeting region-specific healthcare needs. The market is characterized by a strong emphasis on innovation, with companies investing heavily in research and development to improve product effectiveness and user experience. There is also a growing trend of digital integration, such as the development of mobile health apps and advanced diagnostic tools. The market is witnessing a shift towards minimally invasive procedures, which further drives competition and fosters the entry of new players. As the market expands, both global and local companies are focusing on regional expansion and increasing access to their products in key urban centers, such as Beijing and Shanghai, where healthcare demand is high.

Report Coverage

The research report offers an in-depth analysis based on Devices, Indications, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The China gastrointestinal products market is expected to continue its growth trajectory, driven by increasing healthcare demands and an aging population.
Technological advancements in diagnostic and therapeutic devices, such as endoscopy and biopsy tools, will enhance market development.
Rising awareness of digestive health and preventive care will lead to greater demand for OTC products and dietary supplements.
The shift towards minimally invasive procedures and non-invasive treatments will drive innovation in medical devices and therapies.
Growing government support for healthcare infrastructure will create new opportunities for gastrointestinal products in both urban and rural areas.
Expansion of digital health solutions, such as mobile apps for monitoring gastrointestinal health, will further propel the market.
The increasing incidence of gastrointestinal disorders, including IBD, GERD, and IBS, will fuel demand for specialized treatments and diagnostic tools.
Competitive pressure will encourage companies to focus on cost-effective solutions and differentiated products to capture a larger market share.
Local players will continue to gain market share by offering affordable alternatives and focusing on regional needs.
Strategic partnerships, acquisitions, and collaborations between global and local players will accelerate market growth and innovation.

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. GASTROINTESTINAL PRODUCTS Market Snapshot 22

2.1.1. China GASTROINTESTINAL PRODUCTS Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : GASTROINTESTINAL PRODUCTS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. GI Disorders on a Rise 26

4.2.2. New and innovative technologies driving the market 27

4.3. Market Restraints 28

4.3.1. Stringent Regulations 28

4.4. Market Opportunities 29

4.4.1. Market Opportunity Analysis 29

4.5. Porter’s Five Forces Analysis 30

4.6. Value Chain Analysis 31

4.7. Buying Criteria 32

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 33

5.1. Import Analysis by China 33

5.1.1. China GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By China, 2018 – 2023 33

5.2. Export Analysis by China 34

5.2.1. China GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By China, 2018 – 2023 34

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 35

6.1. Demand Analysis by China 35

6.1.1. China GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By China, 2018 – 2023 35

6.2. Supply Analysis by China 36

6.2.1. China GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By China, 2018 – 2023 36

CHAPTER NO. 7 : PRODUCTION ANALYSIS 37

7.1. Production Analysis by China 37

7.1.1. China GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By China, 2018 – 2023 37

CHAPTER NO. 8 : PRICE ANALYSIS 38

8.1. Price Analysis by Devices 38

8.1.1. China GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 38

8.1.2. China Devices Market Price, By Devices, 2018 – 2023 38

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 39

9.1. Key Raw Materials and Suppliers 39

9.2. Key Raw Materials Price Trend 39

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 40

10.1. Manufacturing Cost Analysis 40

10.2. Manufacturing Process 40

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 41

11.1. Company Market Share Analysis – 2023 41

11.1.1. China GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Volume, 2023 41

11.1.2. China GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Revenue, 2023 42

11.1.3. China GASTROINTESTINAL PRODUCTS Market: Top 6 Company Market Share, by Revenue, 2023 42

11.1.4. China GASTROINTESTINAL PRODUCTS Market: Top 3 Company Market Share, by Revenue, 2023 43

11.2. China GASTROINTESTINAL PRODUCTS Market Company Volume Market Share, 2023 44

11.3. China GASTROINTESTINAL PRODUCTS Market Company Revenue Market Share, 2023 45

11.4. Company Assessment Metrics, 2023 46

11.4.1. Stars 46

11.4.2. Emerging Leaders 46

11.4.3. Pervasive Players 46

11.4.4. Participants 46

11.5. Start-ups /SMEs Assessment Metrics, 2023 46

11.5.1. Progressive Companies 46

11.5.2. Responsive Companies 46

11.5.3. Dynamic Companies 46

11.5.4. Starting Blocks 46

11.6. Strategic Developments 47

11.6.1. Acquisitions & Mergers 47

New Product Launch 47

China Expansion 47

11.7. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : GASTROINTESTINAL PRODUCTS MARKET – BY DEVICES SEGMENT ANALYSIS 50

13.1. GASTROINTESTINAL PRODUCTS Market Overview, by Devices Segment 50

13.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 51

13.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Devices 52

13.1.3. Incremental Revenue Growth Opportunity, by Devices, 2024 – 2032 52

13.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 53

13.2. Endoscopy Devices 54

13.3. Ablation Devices 55

13.4. Motility Testing Devices 56

13.5. Biospy Devices 57

13.6. Stenting Devices 58

CHAPTER NO. 14 : GASTROINTESTINAL PRODUCTS MARKET – BY INDICATIONS SEGMENT ANALYSIS 59

14.1. GASTROINTESTINAL PRODUCTS Market Overview, by Indications Segment 59

14.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 60

14.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Indications 61

14.1.3. Incremental Revenue Growth Opportunity, by Indications, 2024 – 2032 61

14.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 62

14.2. Gastrointestinal Cancers 63

14.3. Gastroesophageal Reflux Disease 64

14.4. Irritable Bowl Syndrome 65

14.5. Inflammatory Bowel Disease 66

14.6. Other Disease 67

CHAPTER NO. 15 : GASTROINTESTINAL PRODUCTS MARKET – BY END-USER SEGMENT ANALYSIS 68

15.1. GASTROINTESTINAL PRODUCTS Market Overview, by End-user Segment 68

15.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 69

15.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By End-user 70

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 70

15.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 71

15.2. Hospital 72

15.3. Ambulatory Surgical Center & Independent Surgical Center 73

15.4. Clinics 74

15.5. Other End Users 75

CHAPTER NO. 16 : COMPANY PROFILES 76

16.1. Boston Scientific Corporation 76

16.1.1. Company Overview 76

16.1.2. Product Portfolio 76

16.1.3. Swot Analysis 76

16.1.4. Business Strategy 77

16.1.5. Financial Overview 77

16.2. Olympus Corporation 78

16.3. PENTAX Medical 78

16.4. Zhejiang Tiansong Medical Instrument Co 78

16.5. Medtronic 78

16.6. Stryker 78

16.7. Smith & Nephew 78

16.8. Karl Storz 78

16.9. Hoya 78

16.10. Company 10 78

16.11. Company 11 78

16.12. Company 12 78

16.13. Company 13 78

16.14. Company 14 78

List of Figures

FIG NO. 1. China GASTROINTESTINAL PRODUCTS Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for China GASTROINTESTINAL PRODUCTS Market 29

FIG NO. 3. Value Chain Analysis for China GASTROINTESTINAL PRODUCTS Market 30

FIG NO. 4. China GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By China, 2018 – 2023 32

FIG NO. 5. China GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By China, 2018 – 2023 33

FIG NO. 6. China GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By China, 2018 – 2023 34

FIG NO. 7. China GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By China, 2018 – 2023 35

FIG NO. 8. China GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By China, 2018 – 2023 36

FIG NO. 9. China GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. GASTROINTESTINAL PRODUCTS Market – Company Volume Market Share, 2023 43

FIG NO. 18. GASTROINTESTINAL PRODUCTS Market – Company Revenue Market Share, 2023 44

FIG NO. 19. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Devices 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Devices, 2024 – 2032 51

FIG NO. 22. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 52

FIG NO. 23. China GASTROINTESTINAL PRODUCTS Market for Endoscopy Devices, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. China GASTROINTESTINAL PRODUCTS Market for Ablation Devices, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. China GASTROINTESTINAL PRODUCTS Market for Motility Testing Devices, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. China GASTROINTESTINAL PRODUCTS Market for Biospy Devices, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. China GASTROINTESTINAL PRODUCTS Market for Stenting Devices, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Indications 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Indications, 2024 – 2032 60

FIG NO. 31. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 61

FIG NO. 32. China GASTROINTESTINAL PRODUCTS Market for Gastrointestinal Cancers, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. China GASTROINTESTINAL PRODUCTS Market for Gastroesophageal Reflux Disease, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. China GASTROINTESTINAL PRODUCTS Market for Irritable Bowl Syndrome, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. China GASTROINTESTINAL PRODUCTS Market for Inflammatory Bowel Disease, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. China GASTROINTESTINAL PRODUCTS Market for Other Disease, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. China GASTROINTESTINAL PRODUCTS Market for Hospital, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. China GASTROINTESTINAL PRODUCTS Market for Ambulatory Surgical Center & Independent Surgical Center, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. China GASTROINTESTINAL PRODUCTS Market for Clinics, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. China GASTROINTESTINAL PRODUCTS Market for Other End Users, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. China GASTROINTESTINAL PRODUCTS Market for End-user 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Technology, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By Technology 78

FIG NO. 48. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 78

FIG NO. 49. GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018, 2023, 2027 & 2032 79

FIG NO. 50. China GASTROINTESTINAL PRODUCTS Market for Technology 1, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. China GASTROINTESTINAL PRODUCTS Market for Technology 2, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. China GASTROINTESTINAL PRODUCTS Market for Technology 3, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Distribution Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85

FIG NO. 56. GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. China GASTROINTESTINAL PRODUCTS Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. China GASTROINTESTINAL PRODUCTS Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. China GASTROINTESTINAL PRODUCTS Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. China GASTROINTESTINAL PRODUCTS Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. China GASTROINTESTINAL PRODUCTS Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

List of Tables

TABLE NO. 1. : China GASTROINTESTINAL PRODUCTS Market: Snapshot 18

TABLE NO. 2. : Drivers for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 22

TABLE NO. 3. : Restraints for the GASTROINTESTINAL PRODUCTS Market: Impact Analysis 24

TABLE NO. 4. : China GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 34

TABLE NO. 5. : Key Raw Materials & Suppliers 35

TABLE NO. 6. : China GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018 – 2023 (USD Million) 89

TABLE NO. 7. : China GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2024 – 2032 (USD Million) 89

TABLE NO. 8. : China GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018 – 2023 (USD Million) 90

TABLE NO. 9. : China GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2024 – 2032 (USD Million) 90

TABLE NO. 10. : China GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018 – 2023 (USD Million) 91

TABLE NO. 11. : China GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2024 – 2032 (USD Million) 91

TABLE NO. 12. : China GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018 – 2023 (USD Million) 92

TABLE NO. 13. : China GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2024 – 2032 (USD Million) 92

TABLE NO. 14. : China GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93

TABLE NO. 15. : China GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions

What is the current size of the China Gastrointestinal Products market?

The China gastrointestinal products market was valued at USD 1,679.04 million in 2023 and is projected to reach USD 3,375.67 million by 2032, growing at a compound annual growth rate (CAGR) of 8.06%.

What factors are driving the growth of the China Gastrointestinal Products market?

The market is driven by the increasing prevalence of gastrointestinal disorders such as GERD, IBS, and IBD, rising awareness about digestive health, a growing aging population, advancements in pharmaceutical formulations and drug delivery systems, and the demand for over-the-counter (OTC) products and natural remedies.

What are the key segments within the China Gastrointestinal Products market?

The key segments are:
• Devices: Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, and Stenting Devices.
• Indications: Gastrointestinal Cancers, GERD, IBS, IBD, and Other Diseases.
• End-Users: Hospitals, Ambulatory Surgical Centers, Clinics, and Others.
• Geography: Beijing, Shanghai, Guangzhou, and other regions.

What are some challenges faced by the China Gastrointestinal Products market?

Challenges include navigating stringent regulatory requirements, high costs associated with advanced diagnostic and therapeutic devices, intense market competition, price sensitivity among consumers, and the growing presence of affordable generic products.

Who are the major players in the China Gastrointestinal Products market?

Key players include Boston Scientific Corporation, Olympus Corporation, PENTAX Medical, Zhejiang Tiansong Medical Instrument Co., Medtronic, Stryker, Smith & Nephew, Karl Storz, and Hoya, among others. These companies focus on innovation, advanced technologies, and strategic partnerships to maintain market leadership.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –